Andrew Hirsch - 26 May 2022 Form 4/A - Amendment Insider Report for C4 Therapeutics, Inc. (CCCC)

Role: President & CEO, Director
Signature: /s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol: CCCC
Transactions as of: 26 May 2022
Net transactions value: -$25,762
Form type: 4/A - Amendment
Filing time: 14 Jun 2022, 16:45:52 UTC
Date Of Original Report: 27 May 2022
Previous filing: 27 May 2022
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCCC	Common Stock	Tax liability	$25,762	-3,675	-16%	$7.01	18,825	26 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of performance restricted stock units and does not represent a sale by the Reporting Person.

Remarks:

This Form 4/A is being filed to disclose shares withheld to satisfy tax withholding obligations which were inadvertently omitted from the original Form 4 filing.